Comparable stake leader
TD SECURITIES (USA) LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001849380.
Comparable stake leader
TD SECURITIES (USA) LLC
Disclosed value leader
Savant Capital, LLC
Comparable rows
1/41
Latest evidence
09 Oct 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
1 of 41 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TD SECURITIES (USA) LLC |
13D/G
|
6.2%
Reported 13D/G
· 30 Sep 2025
|
$3,297,618
3,025,338 shares
|
+$60,209 | 30 Sep 2025 |
| Shaolin Capital Management LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$4,192,000
400,000 shares
|
— | 12 Jan 2023 |
| Thomas Kosasa |
3/4/5
Director, 10%+ Owner
|
—
denominator unverified
|
$1,410,320
1,983,573 shares
|
+$2,099,999 | 07 Oct 2026 |
| Jeffrey Yu |
3/4/5
Chief Medical Officer, Director, 10%+ Owner
|
—
mixed-class rows
|
$731,112
1,033,983 shares
mixed-class rows
|
+$1,040,000 | 09 Oct 2026 |
| Savant Capital, LLC |
13F
Company
|
—
mixed-class rows
|
$5,173,936
8,090,987 shares
mixed-class rows
|
— | 30 Jun 2026 |
| Andrew B. Zeinfeld |
3/4/5
Director
|
—
denominator unverified
|
$839,355
381,525 shares
|
— | 14 Aug 2024 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$819,221
1,152,210 shares
|
— | 30 Jun 2026 |
| Jair Clarke |
3/4/5
Director
|
—
denominator unverified
|
$304,667
138,485 shares
|
— | 01 Oct 2024 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to buying over the last 12 months. Net value: +$3,117,803.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 1,592,132 | 0 | $1,090,000 | $0 | +$1,090,000 |
| 3-6 | 850,963 | 0 | $601,708 | $0 | +$601,708 |
| 6-9 | 1,779,750 | 0 | $1,499,999 | $0 | +$1,499,999 |
| 9-12 | 0 | 61,555 | $0 | $73,903 | -$73,903 |
Reporting owners
Showing 1-18 of 18 reporting-owner rows connected to OneMedNet Corp. Open a relationship link for the CIK-to-CIK filing trail.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey Yu | ONMD | Common Stock | Purchase | 5.3% | 45,126 | 896,840 | 09 Oct 2026 | Direct | ||
| Thomas Kosasa | ONMD | Common Stock | Purchase | 7% | 129,758 | 1,983,573 | 07 Oct 2026 | Direct | ||
| Aaron Green | ONMD | Common Stock | Sale | -0.67% | -1,667 | 247,971 | 24 Sep 2026 | Direct | ||
| Aaron Green | ONMD | Common Stock | Sale | -1.96% | -5,000 | 249,638 | 22 Sep 2026 | Direct | ||
| Robert Lawrence Golden | ONMD | Common Stock | Sale | -3.18% | -3,000 | 91,291 | 21 Sep 2026 | Direct | ||
| Robert Lawrence Golden | ONMD | Common Stock | Sale | -3.08% | -3,000 | 94,291 | 15 Sep 2026 | Direct | ||
| Robert Lawrence Golden | ONMD | Common Stock | Sale | -2.51% | -2,500 | 97,291 | 14 Sep 2026 | Direct | ||
| Jeffrey Yu | ONMD | Common Stock | Purchase | 1.63% | $90,000 | $0.6300 | 142,857 | 8,923,267 | 10 Sep 2026 | Direct |
| Thomas Kosasa | ONMD | Common Stock | Purchase | 8.48% | $1,000,000 | $0.6900 | 1,449,275 | 18,538,150 | 30 Jul 2026 | Direct |
| Robert Lawrence Golden | ONMD | Common Stock | Award | 54% | 35,000 | 99,791 | 06 Jul 2026 | Direct | ||
| Aaron Green | ONMD | Common Stock | Award | 34.3% | 65,000 | 254,638 | 06 Jul 2026 | Direct | ||
| Aaron Green | ONMD | Common Stock | Purchase | 1.97% | $21,011 | $0.5733 | 36,650 | 1,896,375 | 23 Jun 2026 | Direct |
| Jeffrey Yu | ONMD | Common Stock | Purchase | 1.84% | $100,000 | $0.6300 | 158,730 | 8,780,410 | 23 Jun 2026 | Direct |
| Jeffrey Yu | ONMD | Common Stock | Purchase | 2.04% | $100,000 | $0.5800 | 172,414 | 8,621,680 | 16 Jun 2026 | Direct |
| Aaron Green | ONMD | Common Stock | Purchase | 1.02% | $10,092 | $0.5396 | 18,702 | 1,859,725 | 15 Jun 2026 | Direct |
| Aaron Green | ONMD | Common Stock | Purchase | 2.05% | $20,605 | $0.5581 | 36,920 | 1,841,023 | 12 Jun 2026 | Direct |
| Thomas Kosasa | ONMD | Common Stock | Purchase | 0.94% | $100,000 | $0.6300 | 158,730 | 17,088,874 | 12 Jun 2026 | Direct |
| Thomas Kosasa | ONMD | Common Stock | Purchase | 1.61% | $250,000 | $0.9300 | 268,817 | 16,930,144 | 18 May 2026 | Direct |
| Thomas Kosasa | ONMD | Common Stock | Purchase | 1.71% | $249,999 | $0.8900 | 280,898 | 16,661,327 | 23 Apr 2026 | Direct |
| Jeffrey Yu | ONMD | Common Stock | Award | 2.67% | 219,429 | 8,449,266 | 01 Apr 2026 | Direct | ||
| Jeffrey Yu | ONMD | Common Stock | Purchase | 12.3% | $750,000 | $0.8300 | 903,614 | 8,229,837 | 01 Apr 2026 | Direct |
| Thomas Kosasa | ONMD | Common Stock | Purchase | 3.77% | $500,000 | $0.8400 | 595,238 | 16,380,429 | 06 Feb 2026 | Direct |
| Robert Lawrence Golden | ONMD | Common Stock | Award | 18.2% | 10,000 | 64,791 | 01 Jan 2026 | Direct | ||
| Jeffrey Yu | ONMD | Common Stock | Award | 0.62% | 45,000 | 7,326,223 | 26 Nov 2025 | Direct | ||
| Robert Lawrence Golden | ONMD | Common Stock | Award | 8.95% | 45,000 | 547,905 | 26 Nov 2025 | Direct | ||
| Aaron Green | ONMD | Common Stock | Award | 2.39% | 45,000 | 1,930,425 | 26 Nov 2025 | Direct | ||
| Sherry Coonse McCraw | ONMD | Common Stock | Award | 396.8% | 45,000 | 56,342 | 26 Nov 2025 | Direct | ||
| Thomas Kosasa | ONMD | Common Stock | Award | 0.29% | 45,000 | 15,785,191 | 26 Nov 2025 | Direct | ||
| Jair Clarke | ONMD | Common Stock | Award | 48.1% | 45,000 | 138,485 | 26 Nov 2025 | Direct | ||
| Andrew B. Zeinfeld | ONMD | Common Stock | Award | 13.4% | 45,000 | 381,525 | 26 Nov 2025 | Direct | ||
| Eric Casaburi | ONMD | Common Stock | Award | 68.7% | 45,000 | 110,475 | 26 Nov 2025 | Direct | ||
| Kenneth Alleyne | ONMD | Common Stock | Award | 38,219 | 38,219 | 26 Nov 2025 | Direct | |||
| Jeffrey Yu | ONMD | Common Stock | Award | 2.82% | 200,000 | 7,281,223 | 24 Nov 2025 | Direct | ||
| Robert Lawrence Golden | ONMD | Common Stock | Award | 196.6% | 333,333 | 502,905 | 24 Nov 2025 | Direct | ||
| Aaron Green | ONMD | Common Stock | Award | 112.9% | 1,000,000 | 1,885,425 | 24 Nov 2025 | Direct | ||
| Aaron Green | ONMD | Common Stock | Sale | -3.3% | -$73,903 | $1.20 | -61,555 | 1,804,103 | 18 Nov 2025 | Direct |